Figure 5
From: Perlecan domain 1 recombinant proteoglycan augments BMP-2 activity and osteogenesis
A: Plasmid map of the codon-modified perlecan D1 expression construct used for in vivo expression analysis. B: sequence of the codon-modifed perlecan D1 transgene employed for in vivo expression analysis.